Luis António Marques da Costa
AuthID: R-000-9BT
141
TITLE: Parathyroid Hormone-related Protein (PTHrP) expression in human bone and liver metastases Full Text
AUTHORS: Costa, L; Fernandes, A; Oliveira, A; Leitzel, K; Ali, S; Schaller, J; Demers, L; Guise, T; Lipton, A;
PUBLISHED: 2005, SOURCE: EJC SUPPLEMENTS, VOLUME: 3, ISSUE: 2
AUTHORS: Costa, L; Fernandes, A; Oliveira, A; Leitzel, K; Ali, S; Schaller, J; Demers, L; Guise, T; Lipton, A;
PUBLISHED: 2005, SOURCE: EJC SUPPLEMENTS, VOLUME: 3, ISSUE: 2
INDEXED IN: 
WOS
WOS142
TITLE: Duration of chemotherapy in non-small-cell lung cancer: Multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine. (Portuguese Lung Cancer Study Group 03/03) Full Text
AUTHORS: Barata, F; Parente, B; Teixeira, E; Nogueira, F; Fernandes, A; Cunha, J; Araujo, A; Costa, A; Valente, L; Ferreira, L;
PUBLISHED: 2005, SOURCE: 11th World Conference on Lung Cancer in LUNG CANCER, VOLUME: 49
AUTHORS: Barata, F; Parente, B; Teixeira, E; Nogueira, F; Fernandes, A; Cunha, J; Araujo, A; Costa, A; Valente, L; Ferreira, L;
PUBLISHED: 2005, SOURCE: 11th World Conference on Lung Cancer in LUNG CANCER, VOLUME: 49
INDEXED IN: WOS 
CrossRef
WOS CrossRef143
TITLE: Parathyroid hormone-related protein (PTHrP) expression in human bone metastases (BM) correlates with the incidence of pathologic fractures
AUTHORS: Costa, L; Fernandes, A; Oliveira, AG; Leitzel, K; Ali, S; Schaller, J; Demers, L; Guise, T; Lipton, A;
PUBLISHED: 2005, SOURCE: 5th International Conference on Cancer Induced Bone Disease (CIBD) in CANCER TREATMENT REVIEWS, VOLUME: 31
AUTHORS: Costa, L; Fernandes, A; Oliveira, AG; Leitzel, K; Ali, S; Schaller, J; Demers, L; Guise, T; Lipton, A;
PUBLISHED: 2005, SOURCE: 5th International Conference on Cancer Induced Bone Disease (CIBD) in CANCER TREATMENT REVIEWS, VOLUME: 31
INDEXED IN: WOS
WOS144
TITLE: Parathyroid hormone-related protein (PTHrp) expression in human bone metastases (BM).
AUTHORS: Costa, L; Fernandes, A; Oliveira, AG; Leitzel, K; Ali, S; Schaller, J; Demers, L; Guise, T; Lipton, A;
PUBLISHED: 2004, SOURCE: 40th Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 22, ISSUE: 14
AUTHORS: Costa, L; Fernandes, A; Oliveira, AG; Leitzel, K; Ali, S; Schaller, J; Demers, L; Guise, T; Lipton, A;
PUBLISHED: 2004, SOURCE: 40th Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 22, ISSUE: 14
INDEXED IN: WOS
WOS145
TITLE: Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis
AUTHORS: Ali, SM; Demers, LM; Leitzel, K; Harvey, HA; Clemens, D; Mallinak, N; Engle, L; Chinchilli, V; Costa, L; Brady, C; Seaman, J; Lipton, A;
PUBLISHED: 2004, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 15, ISSUE: 3
AUTHORS: Ali, SM; Demers, LM; Leitzel, K; Harvey, HA; Clemens, D; Mallinak, N; Engle, L; Chinchilli, V; Costa, L; Brady, C; Seaman, J; Lipton, A;
PUBLISHED: 2004, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 15, ISSUE: 3
146
TITLE: Use of markers of bone turnover for monitoring bone metastases and the response to therapy
AUTHORS: Lipton, A; Costa, L; Ali, S; Demers, L;
PUBLISHED: 2001, SOURCE: Roundtable Discussion Meeting Update on the Role of Bisphosphonates in Metastases in SEMINARS IN ONCOLOGY, VOLUME: 28, ISSUE: 4
AUTHORS: Lipton, A; Costa, L; Ali, S; Demers, L;
PUBLISHED: 2001, SOURCE: Roundtable Discussion Meeting Update on the Role of Bisphosphonates in Metastases in SEMINARS IN ONCOLOGY, VOLUME: 28, ISSUE: 4
INDEXED IN: 
Scopus WOS
Scopus WOS147
TITLE: Bone markers in the management of metastatic bone disease Full Text
AUTHORS: Lipton, A; Costa, L; Ali, SM; Demers, LM;
PUBLISHED: 2001, SOURCE: International Workshop on Bone Biochemical Markers in Oncology in CANCER TREATMENT REVIEWS, VOLUME: 27, ISSUE: 3
AUTHORS: Lipton, A; Costa, L; Ali, SM; Demers, LM;
PUBLISHED: 2001, SOURCE: International Workshop on Bone Biochemical Markers in Oncology in CANCER TREATMENT REVIEWS, VOLUME: 27, ISSUE: 3
INDEXED IN: WOS
WOS148
TITLE: Growth Factors Regulate Heterogeneous Nuclear Ribonucleoprotein K Expression and Function
AUTHORS: Mandal, M; Vadlamudi, R; Nguyen, D; Wang, RA; Costa, L; Bagheri Yarmand, R; Mendelsohn, J; Kumar, R;
PUBLISHED: 2001, SOURCE: Journal of Biological Chemistry, VOLUME: 276, ISSUE: 13
AUTHORS: Mandal, M; Vadlamudi, R; Nguyen, D; Wang, RA; Costa, L; Bagheri Yarmand, R; Mendelsohn, J; Kumar, R;
PUBLISHED: 2001, SOURCE: Journal of Biological Chemistry, VOLUME: 276, ISSUE: 13
149
TITLE: Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells
AUTHORS: Vadlamudi, R; Adam, L; Tseng, B; Costa, L; Kumar, R;
PUBLISHED: 1999, SOURCE: CANCER RESEARCH, VOLUME: 59, ISSUE: 12
AUTHORS: Vadlamudi, R; Adam, L; Tseng, B; Costa, L; Kumar, R;
PUBLISHED: 1999, SOURCE: CANCER RESEARCH, VOLUME: 59, ISSUE: 12
INDEXED IN: Scopus WOS
Scopus WOS150
TITLE: Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma Full Text
AUTHORS: Costa, LAM; Kopreski, MS; Demers, LM; Chinchilli, VM; Santen, RJ; Harvey, HA; Lipton, A;
PUBLISHED: 1999, SOURCE: CANCER, VOLUME: 85, ISSUE: 1
AUTHORS: Costa, LAM; Kopreski, MS; Demers, LM; Chinchilli, VM; Santen, RJ; Harvey, HA; Lipton, A;
PUBLISHED: 1999, SOURCE: CANCER, VOLUME: 85, ISSUE: 1
